NCT03932305View on ClinicalTrials.gov

Randomized Controlled Trial of LUtein as a Novel Neuroprotective Adjunctive Therapy to Improve Visual Outcome of Rhegmatogenous Retinal Detachment (LUNAR Study)

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

July 25, 2016

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Retinal Detachment
Interventions
DIETARY_SUPPLEMENT

Lutein

Lutein is a common oral supplement that may have neuroprotective effect on the human retina

DIETARY_SUPPLEMENT

Placebo

Inactive placebo tablet

All Listed Sponsors
lead

Singapore National Eye Centre

OTHER_GOV

NCT03932305 - Randomized Controlled Trial of LUtein as a Novel Neuroprotective Adjunctive Therapy to Improve Visual Outcome of Rhegmatogenous Retinal Detachment (LUNAR Study) | Biotech Hunter | Biotech Hunter